Following the Food and Drug Administration’s late December 2025 approval of the Wegovy pill—the first oral semaglutide designed for weight management—patients and physicians have grappled with complex dosing choices, according to medical experts. The medication became available to patients in early January 2026, prompting immediate questions about how the oral option compares to traditional weekly … Read more
Vivodyne, a biotech startup operating near San Francisco, has opened a massive biological data center designed to test drugs on lab-grown human tissues using artificial intelligence, according to company disclosures. The facility features twelve robotic mini-labs that use human cells to grow over twenty different types of organ tissues on biological chips, matching the size … Read more
The Food and Drug Administration has approved daraxonrasib, an oral tablet branded as Rasonque, for adults with metastatic pancreatic adenocarcinoma, providing a groundbreaking treatment that reduced the risk of death by 60% in phase 3 trials, according to Revolution Medicines and BioPharma Dive. Patients receiving the medication lived 13.2 months, compared to 6.7 months for … Read more
Eli Lilly Expands Early Access to Retatrutide Following Patient Advocacy Eli Lilly has confirmed it will allow a broader range of patients to apply for early access to its unapproved obesity drug, retatrutide. The decision follows a report by STAT regarding a 79-year-old patient who previously received special access to the medication. The pharmaceutical company … Read more
Food and Drug Administration (FDA). The nationwide recall involves multiple dosage strengths of Levothyroxine Sodium Tablets packaged in 10-count blister packs. Levothyroxine Sodium Tablets Recall Details and Classifications According to the FDA, the recall was initiated on July 13 and designated as a Class II on July 17. A Class II designation indicates that the … Read more
Food and Drug Administration, according to Gray News. Designed for adults and children aged 12 and older, the single tablet combines two of the most widely used OTC pain relievers in the United States to offer up to 12 hours of relief for minor aches and pains. FDA Approval Details for Tylenol with Naproxen The … Read more
Levothyroxine sodium tablets distributed by Major Pharmaceuticals have been pulled from shelves nationwide in a Class II recall announced by the Food and Drug Administration. According to Prevention, certain lots of the widely prescribed medication are “subpotent,” meaning they may fail to deliver the full prescribed dose required by patients managing an underactive thyroid or … Read more
According to the U.S. Food and Drug Administration (FDA), Unique Pharmaceutical Laboratories is recalling nationwide lots of 5-mg cetirizine hydrochloride tablets—an over-the-counter antihistamine commonly sold as a generic version of Zyrtec—due to cross-contamination with ranitidine, a medication formerly marketed as Zantac used for heartburn and indigestion. The mix-up poses life-threatening anaphylaxis risks for individuals with … Read more
An advisory committee voted narrowly on Thursday to recommend that the Food and Drug Administration reclassify four popular peptide therapies, potentially allowing compounding pharmacies to legally dispense the unapproved substances. According to federal proceedings, the panel’s eight-to-six vote with one abstention followed an 11-hour meeting regarding the substances BPC-157, KPV, and TB-500, while a fourth … Read more
Researchers at Yale University found that patients can obtain GLP-1 prescriptions from online platforms in as little as five minutes using fake profiles, raising significant concerns about the level of clinical oversight in direct-to-consumer healthcare. A study published July 6 in the JAMA medical journal revealed that 45 out of 49 websites tested issued prescriptions … Read more